Form 4 for MRK Merck & Co.
Accepted 2024-01-24 00:00:00 ET · period of report 2024-01-22 · accession 0001127602-24-002011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-24 | 2024-01-22 | MRK | Litchfield Caroline | EVP, CFO | A - Grant | $119.43 | +19.2K | 50.9K | +61% | +$2.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-22 | A | A | 19,208 | $119.43 | 50,908.19 | D | — | — | (F1) Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023. (F2) Holdings include shares acquired in dividend reinvestment transactions. |